EUVIMEDEUVIMED entdecken
Validierungsstudie

A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring

Bo Li, Wenqian Chen, Fang Liu, Xiaoxue Wang, Wei Qin, Shu Li, Hongkai Lu, Guan Wang, Xiaoyang Liu, Pengmei Li, Xianbo Zuo, Xianglin Zhang und 2 weitere

Journal of Pharmaceutical and Biomedical Analysis · 2023

DOI: 10.1016/j.jpba.2023.115697 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023. Verfasst von Bo Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China. Hauptthemen laut MEDLINE: Drug Monitoring, Gefitinib, Crown Ethers, Quinazolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringGefitinibCrown EthersQuinazolinesProtein Kinase InhibitorsAntineoplastic AgentsHumansTandem Mass SpectrometryChromatography, High Pressure LiquidAcrylamidesAniline CompoundsReproducibility of ResultsLimit of DetectionPyrimidinesLiquid Chromatography-Mass SpectrometryIndoles

Stichwörter der Autor:innen

GefitinibIcotinibO-demesthyl gefitinibOsimertinibTherapeutic drug monitoringUPLC-MS/MS

Substanzen

icotinibGefitinibCrown EthersosimertinibAcrylamidesQuinazolinesProtein Kinase InhibitorsAniline CompoundsAntineoplastic AgentsPyrimidines

Autor:innen und Institutionen

  • Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
  • Department of Blood Transfusion, China-Japan Friendship Hospital, Beijing 100029, China.
  • Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China; Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: hongllh@126.com.
  • National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of…

Zitieren

APA

Li, B., Chen, W., Liu, F., Wang, X., Qin, W., Li, S., Lu, H., Wang, G., Liu, X., Li, P., Zuo, X., Zhang, X., Liu, L., & Yang, M. (2023). A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2023.115697

Vancouver

Li B, Chen W, Liu F, Wang X, Qin W, Li S, et al. A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 2023. doi:10.1016/j.jpba.2023.115697

BibTeX
@article{Li2023,
  author = {Li, Bo and Chen, Wenqian and Liu, Fang and Wang, Xiaoxue and Qin, Wei and Li, Shu and Lu, Hongkai and Wang, Guan and Liu, Xiaoyang and Li, Pengmei and Zuo, Xianbo and Zhang, Xianglin and Liu, Lihong and Yang, Meng},
  title = {A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  doi = {10.1016/j.jpba.2023.115697}
}
Kostenlos starten →